Membership Levels

There are four different types of PPTA membership: Global, Regional, Source, and Associate.

Global Membership

Global membership is available to businesses or groups of businesses engaged in the manufacture of plasma protein therapies that meet the following criteria:

  • Engage in the manufacture and international marketing of products
  • Operate facilities with a fractionation capacity at least 500,000 liters annually with the facilities and products licensed by appropriate national and regional regulatory authorities
  • Manufacture a broad range of products including, for example, albumin, coagulation factors, Factor VIII and Factor IX, and Immune globulin
  • Demonstrated commitment to the improvement and development of products as demonstrated by an annual investment in research and development
  • Have products registered or pending registration in ten or more countries located in three or more continents
  • Adhere to the highest standards of conduct as described in the Code of Ethics
Regional Membership

Regional membership (i.e., Europe, North America) is available and limited to businesses or groups of businesses engaged in the manufacture of products in two or fewer continents that meet each of the following criteria:

  • Engage in the manufacture and international marketing of products
  • Operate their own facilities with fractionation capacity less than 500,000 liters annually with the facilities and products licensed by appropriate national/regional regulatory authorities, provided that such fractionation capacity does not apply to companies that produce substitute products through alternative technologies; and provided further that any company that meets the eligibility requirements for Regional Membership but has fractionation capacity of 500,000 liters or more shall be eligible for global membership only
  • Committed to the improvement and development of products as demonstrated by an annual investment in research and development
  • Adhere to the highest standards of conduct as described in the Code of Ethics
Source Membership

Source Membership is available to organizations engaged in the collecting, manufacturing, processing or distributing of plasma for further manufacture and that adhere to the highest standards of conduct as described in the Code of Ethics.

Associate Membership

Associate Membership is available to organizations or groups of organizations providing services to businesses or organizations that qualify for either Global, Regional or Source membership in the Association. Associate members shall not be eligible to vote on Association matters or to hold office as directors or officers of the Association.

For information on how to become a member of PPTA, contact the Membership Services office of PPTA, by calling 202-789-3100 or by emailing cizzi@pptaglobal.org.

PPTA News

  • HHS Launches Plasma and Blood Donation Campaign +

    On August 4, the U.S. Department of Health and Human Services (HHS) launched a new nationwide campaign, Giving=Living, intended to draw awareness to the importance of plasma and blood donation, especially following a steep decline in both caused by the Covid pandemic.

    Read More
  • PPTA Statement on the draft EU Substances of Human Origin Regulation +

    PPTA welcomes positive developments but regrets missed opportunities to support plasma donors and patients who rely on plasma-derived medicinal products (PDMPs)

    Brussels, Belgium (July 14, 2022). While the text of the draft regulation on Substances of Human Origin (SoHo) addresses a number of PPTA’s concerns, it has missed the opportunity to help Member States increase plasma collection to improve the reliable availability of life-saving, plasma-derived therapies to patients with a wide range of rare and complex, chronic diseases. As much as 38% of the plasma used to produce medicines for the EU’s 300,000 rare disease patients who rely on PDMPs comes from the U.S., a reliance highlighted during the pandemic, when critical plasma donations declined significantly.

    Read More
  • Monkeypox Virus and Plasma Protein Therapies +

    PPTA considers that the current MPXV outbreak is not a concern for the safety margins of plasma protein therapies manufactured by PPTA member companies. This assessment is also shared by other concerned parties (AABB, WHO).

    Since May 2022, Monkeypox virus (MPXV) infections have been reported in non-endemic countries across Europe and North America (WHO, CDC, ECDC). People who use plasma protein therapies are understandably concerned about whether their therapies remain safe, with respect to MPXV. To address this issue, PPTA has summarized currently available facts. 

    Read More
  • Announcing PPTA’s New Global Chair +

    It is with great pleasure that the Plasma Protein Therapeutics Association (PPTA) announces the election of Giles Platford from Takeda to the Chair of the PPTA Global Board.

    Read More
  • 1
  • 2
  • 3

Cover The Source Summer2019
The Source, the international magazine of the plasma protein therapeutics industry, is published three times a year.

donatingplasma

Learn more about the need for plasma donors, plasma donation, and how you can save and improve lives. Find a Donation Center.

donatingplasma

The need for plasma and plasma donors is more urgent than ever before. Visit givingplasma.org to learn more and to find a donation center near you.

donatingplasma

"How Is Your Day?" is an initiative to raise awareness of the unique nature of plasma protein therapies and the value they provide to patients. It aims to inform and educate decision makers and the general public worldwide.

Get involved and follow "How Is Your Day?" on social media @HIYDglobal
 Icon Twitter  Icon Facebook

Copyright © 2022 PPTA. All rights reserved. (202) 789-3100